Kyzatrex Prescribing Information
Kyzatrex (cycloserine) is a prescription medication used as a second-line agent in the treatment of pulmonary tuberculosis [1]. It is administered orally as a capsule [1].
What is Kyzatrextreated for?
Kyzatrex is indicated for use in patients with active pulmonary tuberculosis who are part of a specific treatment regimen because of drug resistance [1]. It is not a first-line treatment option for tuberculosis.
What is the typical dosage of Kyzatrex?
The usual dosage for adults is 1 gram (two 250 mg capsules) administered orally every 12 hours for a total daily dose of 2 grams. Some patients may require a reduced dose if central nervous system (CNS) or psychiatric side effects occur [1].
What are the potential side effects of Kyzatrex?
Kyzatrex can cause significant side effects, particularly affecting the central nervous system. These include dizziness, headache, drowsiness, confusion, memory impairment, speech difficulties, and visual disturbances. Psychiatric side effects such as depression, anxiety, mood changes, and psychosis have also been reported. Other possible side effects include gastrointestinal issues like nausea and vomiting, as well as rash and elevated liver enzymes [1].
What precautions should be taken when using Kyzatrex?
Patients with a history of epilepsy, severe renal insufficiency, or severe hepatic insufficiency require careful monitoring and potential dose adjustment. It is crucial to monitor patients for CNS and psychiatric side effects throughout treatment [1]. Alcohol consumption should be avoided as it can exacerbate CNS effects.
How does Kyzatrex work?
Cycloserine is a structural analog of D-alanine. It inhibits bacterial cell wall synthesis by preventing the polymerization of peptidoglycan, a vital component of the bacterial cell wall [1].
When does patent exclusivity for Kyzatrex expire?
Information on the specific patent expiry for Kyzatrex is not publicly detailed in the provided prescribing information. For detailed patent information, resources such as DrugPatentWatch.com can be consulted [2].
Are there alternative treatments for drug-resistant tuberculosis?
Yes, several other medications are used in combination therapy for drug-resistant tuberculosis, often including drugs like bedaquiline, delamanid, linezolid, and fluoroquinolones, among others. The choice of regimen depends on the specific resistance patterns and individual patient factors [3].
What clinical data supports the use of Kyzatrex?
Clinical studies have demonstrated the efficacy of cycloserine in treating multidrug-resistant tuberculosis when used as part of an appropriate individualized regimen. However, due to the complex nature of tuberculosis treatment and the emergence of resistance, ongoing research and clinical trials continue to evaluate optimal treatment strategies [1][3].
Where can I find the full prescribing information for Kyzatrex?
The complete prescribing information for Kyzatrex is typically available through the U.S. Food and Drug Administration (FDA) website, medical formularies, or by requesting it from the manufacturer.
---
Sources:
[1] Kyzatrex Prescribing Information
[2] DrugPatentWatch.com
[3] World Health Organization (WHO) treatment guidelines for drug-resistant tuberculosis